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LOCALIZED AGGRESSIVE NHL
rationale
BACKGROUND.      Brief chemotherapy followed    
by IFRT is considered as the standard treatment.
• 3 cycles of CHOP + IFRT > 8 cycles of CHOP                      
(Miller et al., NEJM, 1998, 339:21) However patients enrolled 
in this study were heterogeneous with regard to major 
prognostic factors of the IPI.
QUESTION. What is the role for radiotherapy ?
METHOD.                The GELA designed the present 
LNH 93-4 study to compare radiotherapy versus 
nothing after 4 cycles of chemotherapy.
LNH 93-4
inclusion criteria
• Age  60 y
Stage : I - II
• a.a. IPI = 0 LDH :  1 N
PS : < 2
• WF histology F, G, H, anaplastic
LNH 93-4
study design
CHOP 21 X 4
CHOP 21 X 4 + IFRT 40 Gy
(5 x 1,8 Gy/wk)
Stratified according to center and  bulk (  10 cm)
R
CHOP n = 277
• Enrolled (03/93 – 06/02)  n = 576
CHOP + IFRT n = 299
• Intent to treat
• performed histo review :         89 %
• Median follow-up : 7 years
LNH 93-4
LNH 93-4
RESPONSE TO TREATMENT (evaluable in 568 pts)
CHOP CHOP + IFRT
n=273 n=295
CR 89 % 91 %
PR + Failure         9 % 8 %
Death 1 % 1 %
CONCLUSIONS : LNH 93-4
• Only prospective randomized study comparing brief 
chemotherapy alone with the same chemotherapy 
followed by IFRT.
• After 4 cycles of CHOP, IFRT does not increase CR, 
EFS or OS in elderly patients with low-risk 
aggressive NHL.
• Although the majority of patients had stage I disease, 
irradiation did not decrease the overall relapse rate or 
the death rate from lymphoma.
CONCLUSIONS : LNH 93-4
• Radiotherapy should be abandonned in first line 
therapy for localized aggressive NHL.
• Current recommendation of the GELA :
6 - 8 cycles of CHOP21 + Rituximab d1
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